Medicamentos de Suiza

Medicamentos que empiezan por ir

Elija la segunda letra del medicamento:

ia
ib
ic
id
ig
ik
il
im
in
io
ip
iq
ir
is
it
iv
ix

IRBESARTAN HCT ZENTIVA film-coated tablet 150 mg+12.5 mg
Helvepharm AG

IRBESARTAN HCT ZENTIVA film-coated tablet 300 mg+12.5 mg
Helvepharm AG

IRBESARTAN HCT ZENTIVA film-coated tablet 300 mg+25 mg
Helvepharm AG

IRBESARTAN SANDOZ film-coated tablet 150 mg
Sandoz Pharmaceuticals AG

IRBESARTAN SANDOZ film-coated tablet 300 mg
Sandoz Pharmaceuticals AG

IRBESARTAN SPIRIG HC film-coated tablet 150 mg
Spirig HealthCare AG

IRBESARTAN SPIRIG HC film-coated tablet 300 mg
Spirig HealthCare AG

IRBESARTAN ZENTIVA film-coated tablet 150 mg
Helvepharm AG

IRBESARTAN ZENTIVA film-coated tablet 300 mg
Helvepharm AG

IRBESARTAN-HCT-MEPHA film-coated tablet 150 mg+12.5 mg
Mepha Pharma AG

IRBESARTAN-HCT-MEPHA film-coated tablet 300 mg+12.5 mg
Mepha Pharma AG

IRBESARTAN-HCT-MEPHA film-coated tablet 300 mg+25 mg
Mepha Pharma AG

IRBESARTAN-MEPHA film-coated tablet 150 mg
Mepha Pharma AG

IRBESARTAN-MEPHA film-coated tablet 300 mg
Mepha Pharma AG

IRESSA film-coated tablet 250 mg
AstraZeneca SA

IRFEN DOLO film-coated tablet 200 mg
Mepha Pharma AG

IRFEN DOLO film-coated tablet 200 mg+500 mg
Mepha Pharma AG

IRFEN DOLO FORTE film-coated tablet 400 mg
Mepha Pharma AG

IRFEN DOLO JUNIOR SUSPENSION oral suspension 100 mg/5 ml
Mepha Pharma AG

IRFEN DOLO JUNIOR SUSPENSION oral suspension 150 mg/7.5 ml
Mepha Pharma AG

IRFEN DOLO L film-coated tablet 200 mg
Mepha Pharma AG

IRFEN DOLO L FORTE film-coated tablet 400 mg
Mepha Pharma AG

IRFEN JUNIOR SUSPENSION oral suspension 100 mg/5 ml
Mepha Pharma AG

IRFEN RETARD prolonged-release tablet 800 mg
Mepha Pharma AG

IRFEN tablet 200 mg
Mepha Pharma AG

IRFEN tablet 400 mg
Mepha Pharma AG

IRFEN tablet 600 mg
Mepha Pharma AG

IRINOTECAN ACCORD concentrate for solution for infusion 1 000 mg/15 ml
ACCORD HEALTHCARE AG

IRINOTECAN ACCORD concentrate for solution for infusion 100 mg/5 ml
ACCORD HEALTHCARE AG

IRINOTECAN ACCORD concentrate for solution for infusion 300 mg/15 ml
ACCORD HEALTHCARE AG

IRINOTECAN ACCORD concentrate for solution for infusion 40 mg/2 ml
ACCORD HEALTHCARE AG

IRINOTECAN ACCORD concentrate for solution for infusion 500 mg/25 ml
ACCORD HEALTHCARE AG

IRINOTECAN FRESENIUS concentrate for solution for infusion 100 mg/5 ml
Fresenius Kabi (Schweiz) AG

IRINOTECAN FRESENIUS concentrate for solution for infusion 300 mg/15 ml
Fresenius Kabi (Schweiz) AG

IRINOTECAN FRESENIUS concentrate for solution for infusion 40 mg/2 ml
Fresenius Kabi (Schweiz) AG

IRINOTECAN FRESENIUS concentrate for solution for infusion 500 mg/25 ml
Fresenius Kabi (Schweiz) AG

IRINOTECAN LABATEC concentrate for solution for infusion 100 mg/5 ml
Labatec-Pharma SA

IRINOTECAN LABATEC concentrate for solution for infusion 300 mg/15 ml
Labatec-Pharma SA

IRINOTECAN LABATEC concentrate for solution for infusion 40 mg/2 ml
Labatec-Pharma SA

IRINOTECAN LABATEC concentrate for solution for infusion 500 mg/25 ml
Labatec-Pharma SA

IRINOTECAN MMPHARM concentrate for solution for infusion 100 mg/5 ml
mmpharm GmbH

IRINOTECAN MMPHARM concentrate for solution for infusion 300 mg/15 ml
mmpharm GmbH

IRINOTECAN MMPHARM concentrate for solution for infusion 40 mg/2 ml
mmpharm GmbH

IRINOTECAN MMPHARM concentrate for solution for infusion 500 mg/25 ml
mmpharm GmbH

IRINOTECAN SANDOZ ECO concentrate for solution for infusion 100 mg/5 ml
Sandoz Pharmaceuticals AG

IRINOTECAN SANDOZ ECO concentrate for solution for infusion 300 mg/15 ml
Sandoz Pharmaceuticals AG

IRINOTECAN SANDOZ ECO concentrate for solution for infusion 40 mg/2 ml
Sandoz Pharmaceuticals AG

IRINOTECAN SANDOZ ECO concentrate for solution for infusion 500 mg/25 ml
Sandoz Pharmaceuticals AG

IRINOTECAN-TEVA LIQUID concentrate for solution for infusion 100 mg/5 ml
Teva Pharma AG

IRINOTECAN-TEVA LIQUID concentrate for solution for infusion 300 mg/15 ml
Teva Pharma AG

IRINOTECAN-TEVA LIQUID concentrate for solution for infusion 40 mg/2 ml
Teva Pharma AG

IRINOTECAN-TEVA LIQUID concentrate for solution for infusion 500 mg/25 ml
Teva Pharma AG

IROPECT NOUVELLE FORMULE POUR LES BRONCHES lozenge 3 mg
Tentan AG

IROTUSSIN syrup 6.25 mg/5 ml+8.5 mg/5 ml
Tentan AG

IRUXOL MONO ointment 1.2 IU/g
Smith & Nephew AG

© Vidal Vademecum Spain | Cochabamba, 24. 28016 Madrid, España - Tel. 91 579 98 00 - Fax: 91 579 82 29
Vademecum.es está reconocido oficialmente por las autoridades sanitarias correspondientes como Soporte Válido para incluir publicidad de medicamentos o especialidades farmacéuticas de prescripción dirigida a los profesionales sanitarios (S.V.nº09/10-W-CM), concedida el 3 de diciembre de 2010.

Aviso : La información que figura en esta página web, está dirigida exclusivamente al profesional destinado a prescribir o dispensar medicamentos por lo que requiere una formación especializada para su correcta interpretación.

© Vidal Vademecum Spain | Contacte con nosotros | Política de Privacidad | Aviso legal | Política de Cookies | Configurar preferencias Cookies